Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – N-c doai
Reexamination Certificate
2006-08-08
2006-08-08
Richter, Johann (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
N-c doai
C514S484000, C514S489000
Reexamination Certificate
active
07087643
ABSTRACT:
This invention is directed to a method for preventing or treating neuropathic pain and cluster and migraine headache-associated pain comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I):wherein phenyl is substituted at X with one to five halogen atoms independently selected from the group consisting of fluorine, chlorine, bromine and iodine; and; R1, R2, R3and R4are independently selected from the group consisting of hydrogen and C1–C4alkyl; wherein C1–C4alkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of hydrogen, halogen, C1–C4alkyl, C1–C4alkoxy, amino, nitro and cyano).
REFERENCES:
patent: 3265728 (1966-08-01), Bossinger et al.
patent: 3313692 (1967-04-01), Bossinger et al.
patent: 5698588 (1997-12-01), Choi et al.
patent: 5854283 (1998-12-01), Choi et al.
patent: 6103759 (2000-08-01), Choi et al.
patent: 6541513 (2003-04-01), Plata-Salaman et al.
patent: 6562867 (2003-05-01), Plata-Salaman et al.
patent: 6589985 (2003-07-01), Plata-Salaman et al.
patent: 6815464 (2004-11-01), Plata-Salaman et al.
patent: WO 02/07822 (2002-01-01), None
patent: WO 02 67922 (2002-09-01), None
Mulleners, W.M. et al.,Visual Cortex Excitability in Migraine With and Without Aura, Headache, Jun. 2001, 41(6) 565-572.
Aurora, S.K, et al.,The Occipital Cortex is Hyperexcitable in Migrane: Experimental Evidence, Headache. Jul.-Aug. 1999, 39(7), 469-476.
Brau, M.E. et al.,Effect of Drugs Used for Neuropathic Pain Management on Tetrodotoxin-resistant Na(+)Currents in Rat Sensory Neurons, Anesthesiology, 2001, Jan. 94(1), 137-144.
Siddall, P.J. and Loeser, J.D.,Pain Following Spinal Cord Injury, Spinal Cord, 2001, Feb. 39(2) 63-73.
Kontinen, V.K. et al.,Electrophysiologic Evidence for Increased Endogenous Gabaergic But Not Glycinergic Inhibitory Tone in the Rat Spinal Nerve Ligation Model of Neuropathy, Anesthesiology, Feb. 2001, 94(2), 333-339.
Delvaux, F. & Schoenen, J.,New Generation Anti-Epileptics for Facial Pain and Headache, Acta Neurol. Belg., Mar. 2001, 101(1), 42-46.
Johannessen, C.U.,Mechanisms of Action of Valproate: A Commentatory, Neurochem. Int., 2000, Aug.-Sep., 37 (2-3), 103-110.
Magnus, L.,Nonepileptic Uses of Gabapentin, Epilepsia, 1999, 40 Suppl 6, S66-72.
U.S. Appl. No. 09/906,251, Ortho-McNeil Pharmaceutical, Inc.
U.S. Appl. No. 10/081,606, Ortho-McNeil Pharmaceutical, Inc.
U.S. Appl. No. 10/081,713, Ortho-McNeil Pharmaceutical, Inc.
U.S. Appl. No. 10/081,943, Ortho-McNeil Pharmaceutical, Inc.
U.S. Appl. No. 10/192,973, Ortho-McNeil Pharmaceutical, Inc.
U.S. Appl. No. 10/081,764, Ortho-McNeil Pharmaceutical, Inc.
Hansen, “Treatment of Chronic Pain with Anitepileptic Drugs: A New Era”, Southern Medical Journal, vol. 92, No. 7 (Jul. 1999). pp. 642-650.
Codd Ellen C.
Plata-Salaman Carlos R.
Zhao Boyu
Herridge Peter L.
Nwaonicha Chukwuma
Ortho-McNeil Pharmaceutical , Inc.
Richter Johann
LandOfFree
Carbamate compounds for use in preventing or treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbamate compounds for use in preventing or treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbamate compounds for use in preventing or treating... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3706605